Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
about
Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review StudyAzilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapyEffect of Azilsartan on Day-to-Day Variability in Home Blood Pressure: A Prospective Multicenter Clinical Trial.Differential pharmacology and benefit/risk of azilsartan compared to other sartansNew treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil.The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle.Critical evaluation of the efficacy and tolerability of azilsartan.Azilsartan medoxomil: a review of its use in hypertension.Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension.An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats.Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension.Spectrophotometric and spectrofluorimetric studies on azilsartan medoxomil and chlorthalidone to be utilized in their determination in pharmaceuticals.Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.Ability of the new AT1 receptor blocker azilsartan to block angiotensin II-induced AT1 receptor activation after wash-out.Absorption of TAK-491, a new angiotensin II receptor antagonist, in animals.Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics.
P2860
Q26740629-EE5CEAA2-CF65-4E2F-B133-ABDB65969DE2Q26751126-6E1FB108-6E6D-43FB-9A54-8ABAE501E088Q33763329-2822D151-9AF9-424D-851D-D5CD774F470CQ35808748-7098D431-D859-48FC-8089-46632E9094AFQ35841718-96585F62-3F85-427C-9746-45A4F93B04D6Q37039767-393157D2-B03F-40DF-8280-EA229E4E710AQ38015816-91967B90-F9AB-4FAC-BCF4-F87C0C44FE95Q38033252-BDD92C09-8009-4E1B-968E-767563BB0D99Q38079623-29812377-6804-484C-B734-97AA3E93D086Q38096442-39F2A654-CBAA-4174-9F9E-0C18A029F372Q38144197-0F955033-77BD-4C26-B6C8-2E38B438984AQ38258427-15293ED0-8565-4346-BDD1-53463F4C3D8BQ38965224-4A64CF94-0F94-4129-8A7F-64CC1BD20D91Q39264079-53AD189E-0CC1-4D75-96D3-D244ED01461BQ39657942-AC0630EA-D3B6-4FB4-9D96-8B6CA12D8D77Q41880978-2504CA82-D291-43D5-9EA3-A62D32CF29E3Q44587419-E304BD6C-F658-4328-9DEC-D6FC0E598540Q44783949-4C5C2429-BB0F-4B53-B689-991945898499Q45323794-285E2460-EF9C-408F-A73F-18CC9A02320B
P2860
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@en
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@nl
type
label
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@en
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@nl
prefLabel
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@en
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@nl
P2093
P1476
Antihypertensive, insulin-sens ...... oxomil, in rat and dog models.
@en
P2093
Ayako Tsuboi
Fuminari Yamaguchi
Hideaki Nagaya
Hideki Igata
Hiroki Sakamoto
Keiji Kusumoto
Mami Ojima
Mitsuaki Imanishi
Naohiro Kawaguchi
Nobuhiro Nishigaki
P356
10.1016/J.EJPHAR.2011.07.014
P407
P577
2011-07-28T00:00:00Z